What does CUSIP 09073Q204 represent in this 13F holders report?

CUSIP 09073Q204 is the security identifier for SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW used to aggregate holder disclosures.

How many institutions held SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW in Q4 2023?

11 institutional investors reported SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW for Q4 2023. Use the holders table for investor-level position and value details.

SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI)

CUSIP: 09073Q204

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / SPON ADS NEW
Total 13F shares: 462,433
Total 13F value: $275,246
Share change: -152,073
SEC-reported price per share: $0.60
Number of holders: 11
Value change: -$90,572
Number of buys: 4
Number of sells: 2

Security key

09073Q204

Report period

Q4 2023

Institutions

Top holders

SCNI full security history Ownership snapshot Full 13F holder table Scinai Immunotherapeutics Ltd. SEC filings Scinai Immunotherapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

0/12

Latest evidence

30 Sep 2023

13F 3/4/5 Highest disclosed value: $315,330 12 rows are not safely comparable across share classes. Showing 1-6 of 12 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $315.3K.

0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Disclosed position value Top 5

ARMISTICE CAPITAL, LLC $315.3K

SABBY MANAGEMENT, LLC $213.1K

RHUMBLINE ADVISERS $3.1K

MORGAN STANLEY $2K

UBS Group AG $717

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$315,330 362,448 shares	—	30 Sep 2023
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$213,120 244,966 shares	—	30 Sep 2023
RHUMBLINE ADVISERS	13F Company 13F	— denominator unverified	$3,084 3,549 shares	—	30 Sep 2023
MORGAN STANLEY	13F Company 13F	— denominator unverified	$1,985 2,282 shares	—	30 Sep 2023
UBS Group AG	13F Company 13F	— denominator unverified	$717 824 shares	—	30 Sep 2023
Aspire Private Capital, LLC	13F Company 13F	— denominator unverified	$139 160 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

462,433

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %